Genetic pathogenesis of the epileptogenic lesions in Tuberous Sclerosis Complex: Therapeutic targeting of the mTOR pathway
出版年份 2021 全文链接
标题
Genetic pathogenesis of the epileptogenic lesions in Tuberous Sclerosis Complex: Therapeutic targeting of the mTOR pathway
作者
关键词
Tuberous sclerosis complex, mTOR, mTOR inhibitor, Rapamycin, Everolimus, Epilepsy
出版物
EPILEPSY & BEHAVIOR
Volume -, Issue -, Pages 107713
出版商
Elsevier BV
发表日期
2021-01-12
DOI
10.1016/j.yebeh.2020.107713
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Resective epilepsy surgery in tuberous sclerosis complex: a nationwide multicentre retrospective study from China
- (2020) Shiyong Liu et al. BRAIN
- Mechanistic Target of Rapamycin Regulates the Oligodendrocyte Cytoskeleton during Myelination
- (2020) Aminat S. Musah et al. JOURNAL OF NEUROSCIENCE
- TSC2 pathogenic variants are predictive of severe clinical manifestations in TSC infants: results of the EPISTOP study
- (2020) Barbara Ogórek et al. GENETICS IN MEDICINE
- Pilot Study of Neurodevelopmental Impact of Early Epilepsy Surgery in Tuberous Sclerosis Complex
- (2020) Leslie E. Grayson et al. PEDIATRIC NEUROLOGY
- Long-term outcomes of ketogenic diet in patients with tuberous sclerosis complex-derived epilepsy
- (2020) Song Ee Youn et al. EPILEPSY RESEARCH
- Sirolimus improves seizure control in pediatric patients with tuberous sclerosis: A prospective cohort study
- (2020) Wen He et al. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
- Tuberous Sclerosis Complex Genotypes and Developmental Phenotype
- (2019) Laura S. Farach et al. PEDIATRIC NEUROLOGY
- mTOR Hyperactivity Levels Influence the Severity of Epilepsy and Associated Neuropathology in an Experimental Model of Tuberous Sclerosis Complex and Focal Cortical Dysplasia
- (2019) Lena H. Nguyen et al. JOURNAL OF NEUROSCIENCE
- New insights into a spectrum of developmental malformations related to mTOR dysregulations: challenges and perspectives
- (2019) A. Mühlebner et al. JOURNAL OF ANATOMY
- The ALS-FTD-linked gene product, C9orf72, regulates neuronal morphogenesis via autophagy
- (2019) Wan Yun Ho et al. Autophagy
- An update on the central nervous system manifestations of tuberous sclerosis complex
- (2019) Jennifer A. Cotter ACTA NEUROPATHOLOGICA
- Genetic Etiologies, Diagnosis, and Treatment of Tuberous Sclerosis Complex
- (2019) Catherine L. Salussolia et al. Annual Review of Genomics and Human Genetics
- Safety and efficacy of mTOR inhibitor treatment in patients with tuberous sclerosis complex under 2 years of age – a multicenter retrospective study
- (2019) Afshin Saffari et al. Orphanet Journal of Rare Diseases
- GABARAPs dysfunction by autophagy deficiency in adolescent brain impairs GABAA receptor trafficking and social behavior
- (2019) Kelvin K. Hui et al. Science Advances
- A randomized controlled trial with everolimus for IQ and autism in tuberous sclerosis complex
- (2019) Iris E. Overwater et al. NEUROLOGY
- Preventive antiepileptic treatment in tuberous sclerosis complex: long-term, prospective trial
- (2019) Sergiusz Jozwiak et al. PEDIATRIC NEUROLOGY
- Effects of antiepileptic drugs in a new TSC/mTOR-dependent epilepsy mouse model
- (2019) Linda M. C. Koene et al. Annals of Clinical and Translational Neurology
- Precise detection of low-level somatic mutation in resected epilepsy brain tissue
- (2019) Nam Suk Sim et al. ACTA NEUROPATHOLOGICA
- Dissecting the genetic basis of focal cortical dysplasia: a large cohort study
- (2019) Sara Baldassari et al. ACTA NEUROPATHOLOGICA
- Cannabidiol Interacts Significantly with Everolimus—Report of a Patient with Tuberous Sclerosis Complex
- (2019) Adelheid Wiemer-Kruel et al. NEUROPEDIATRICS
- Tuberous sclerosis‐associated epilepsy and intellectual disability: what role does the mammalian target of rapamycin pathway play?
- (2019) Paolo Curatolo DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY
- The coding and non-coding transcriptional landscape of subependymal giant cell astrocytomas
- (2019) Anika Bongaarts et al. BRAIN
- Epileptogenicity in tuberous sclerosis complex: A stereoelectroencephalographic study
- (2019) Andrew Neal et al. EPILEPSIA
- The role of glia in epilepsy, intellectual disability, and other neurodevelopmental disorders in tuberous sclerosis complex
- (2019) Michael Wong Journal of Neurodevelopmental Disorders
- Pathological high frequency oscillations associate with increased GABA synaptic activity in pediatric epilepsy surgery patients
- (2019) Carlos Cepeda et al. NEUROBIOLOGY OF DISEASE
- Cannabidiol Elevates Mechanistic Target of Rapamycin Inhibitor Levels in Patients With Tuberous Sclerosis Complex
- (2019) Daniel Ebrahimi-Fakhari et al. PEDIATRIC NEUROLOGY
- Everolimus dosing recommendations for tuberous sclerosis complex-associated refractory seizures
- (2018) David N. Franz et al. EPILEPSIA
- Short-term safety of mTOR inhibitors in infants and very young children with tuberous sclerosis complex (TSC): Multicentre clinical experience
- (2018) Darcy A. Krueger et al. EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY
- Management of epilepsy associated with tuberous sclerosis complex: Updated clinical recommendations
- (2018) Paolo Curatolo et al. EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY
- mTOR dysregulation and tuberous sclerosis-related epilepsy
- (2018) Paolo Curatolo et al. Expert Review of Neurotherapeutics
- Role of mTOR Complexes in Neurogenesis
- (2018) Francesca LiCausi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Population pharmacokinetics–pharmacodynamics of oral everolimus in patients with seizures associated with tuberous sclerosis complex
- (2018) François Pierre Combes et al. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
- mTOR dysregulation and tuberous sclerosis-related epilepsy
- (2018) Paolo Curatolo et al. Expert Review of Neurotherapeutics
- Everolimus for epilepsy and autism spectrum disorder in tuberous sclerosis complex: EXIST-3 substudy in Japan
- (2018) Masashi Mizuguchi et al. BRAIN & DEVELOPMENT
- Longitudinal Effects of Everolimus on White Matter Diffusion in Tuberous Sclerosis Complex
- (2018) Jurriaan M. Peters et al. PEDIATRIC NEUROLOGY
- Neuron-Glia Interactions Increase Neuronal Phenotypes in Tuberous Sclerosis Complex Patient iPSC-Derived Models
- (2018) Aishwarya G. Nadadhur et al. Stem Cell Reports
- Progress report on new antiepileptic drugs: A summary of the Thirteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XIII)
- (2017) Meir Bialer et al. EPILEPSIA
- TSC1 and TSC2 gene mutations and their implications for treatment in Tuberous Sclerosis Complex: a review
- (2017) Clévia Rosset et al. GENETICS AND MOLECULAR BIOLOGY
- Beneficial Effects of Everolimus on Autism and Attention-Deficit/Hyperactivity Disorder Symptoms in a Group of Patients with Tuberous Sclerosis Complex
- (2017) Ayse Kilincaslan et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- Molecular neurobiology of mTOR
- (2017) Katarzyna Switon et al. NEUROSCIENCE
- Recent Advances and Challenges of mTOR Inhibitors Use in the Treatment of Patients with Tuberous Sclerosis Complex
- (2017) Filipe Palavra et al. Oxidative Medicine and Cellular Longevity
- Resistance to mTORC1 Inhibitors in Cancer Therapy: From Kinase Mutations to Intratumoral Heterogeneity of Kinase Activity
- (2017) Seraina Faes et al. Oxidative Medicine and Cellular Longevity
- The genomic landscape of tuberous sclerosis complex
- (2017) Katie R. Martin et al. Nature Communications
- Variation in a range of mTOR-related genes associates with intracranial volume and intellectual disability
- (2017) M. R. F. Reijnders et al. Nature Communications
- Subependymal giant cell astrocytomas in Tuberous Sclerosis Complex have consistent TSC1/TSC2 biallelic inactivation, and no BRAF mutations
- (2017) Anika Bongaarts et al. Oncotarget
- Centre of epileptogenic tubers generate and propagate seizures in tuberous sclerosis
- (2016) Lakshminarayanan Kannan et al. BRAIN
- Cannabidiol as a new treatment for drug-resistant epilepsy in tuberous sclerosis complex
- (2016) Evan J. Hess et al. EPILEPSIA
- mTOR inhibitor reverses autistic-like social deficit behaviours in adult rats with both Tsc2 haploinsufficiency and developmental status epilepticus
- (2016) Miriam Schneider et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- Early onset epileptic encephalopathy or genetically determined encephalopathy with early onset epilepsy? Lessons learned from TSC
- (2016) Paolo Curatolo et al. EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY
- Structural Basis of the Interaction between Tuberous Sclerosis Complex 1 (TSC1) and Tre2-Bub2-Cdc16 Domain Family Member 7 (TBC1D7)
- (2016) Jiayue Qin et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Specific pattern of maturation and differentiation in the formation of cortical tubers in tuberous sclerosis complex (TSC): evidence from layer-specific marker expression
- (2016) Angelika Mühlebner et al. Journal of Neurodevelopmental Disorders
- Genetic animal models of malformations of cortical development and epilepsy
- (2016) Michael Wong et al. JOURNAL OF NEUROSCIENCE METHODS
- Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study
- (2016) Jacqueline A French et al. LANCET
- Overcoming mTOR resistance mutations with a new-generation mTOR inhibitor
- (2016) Vanessa S. Rodrik-Outmezguine et al. NATURE
- Functional aspects of early brain development are preserved in tuberous sclerosis complex (TSC) epileptogenic lesions
- (2016) Gabriele Ruffolo et al. NEUROBIOLOGY OF DISEASE
- Sirolimus for epilepsy in children with tuberous sclerosis complex
- (2016) Iris E. Overwater et al. NEUROLOGY
- Long-term treatment of epilepsy with everolimus in tuberous sclerosis
- (2016) Darcy A. Krueger et al. NEUROLOGY
- The role of mTOR signalling in neurogenesis, insights from tuberous sclerosis complex
- (2016) Andrew R. Tee et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Novel Histopathological Patterns in Cortical Tubers of Epilepsy Surgery Patients with Tuberous Sclerosis Complex
- (2016) Angelika Mühlebner et al. PLoS One
- Long-Term Use of Everolimus in Patients with Tuberous Sclerosis Complex: Final Results from the EXIST-1 Study
- (2016) David N. Franz et al. PLoS One
- Intermittent dosing of rapamycin maintains antiepileptogenic effects in a mouse model of tuberous sclerosis complex
- (2015) Nicholas Rensing et al. EPILEPSIA
- Neurological and neuropsychiatric aspects of tuberous sclerosis complex
- (2015) Paolo Curatolo et al. LANCET NEUROLOGY
- Differentiating the mTOR inhibitors everolimus and sirolimus in the treatment of tuberous sclerosis complex
- (2015) Jeffrey P. MacKeigan et al. NEURO-ONCOLOGY
- Seizure-dependent mTOR activation in 5-HT neurons promotes autism-like behaviors in mice
- (2015) John J. McMahon et al. NEUROBIOLOGY OF DISEASE
- DTI of tuber and perituberal tissue can predict epileptogenicity in tuberous sclerosis complex
- (2015) Akira Yogi et al. NEUROLOGY
- Genotype/Phenotype Correlations in Tuberous Sclerosis Complex
- (2015) Paolo Curatolo et al. Seminars in Pediatric Neurology
- mTOR Signaling in Epilepsy: Insights from Malformations of Cortical Development
- (2015) P. B. Crino Cold Spring Harbor Perspectives in Medicine
- Developmental brain abnormalities in tuberous sclerosis complex: A comparative tissue analysis of cortical tubers and perituberal cortex
- (2014) Véronique Ruppe et al. EPILEPSIA
- Interictal high frequency oscillations correlating with seizure outcome in patients with widespread epileptic networks in tuberous sclerosis complex
- (2014) Tohru Okanishi et al. EPILEPSIA
- Mammalian Target of Rapamycin Promotes Oligodendrocyte Differentiation, Initiation and Extent of CNS Myelination
- (2014) S. E. Wahl et al. JOURNAL OF NEUROSCIENCE
- Balanced mTORC1 Activity in Oligodendrocytes Is Required for Accurate CNS Myelination
- (2014) F. Lebrun-Julien et al. JOURNAL OF NEUROSCIENCE
- The Neurology of mTOR
- (2014) Jonathan O. Lipton et al. NEURON
- Identification of Regions Critical for the Integrity of the TSC1-TSC2-TBC1D7 Complex
- (2014) Arthur Jorge Santiago Lima et al. PLoS One
- Selective suppression of excessive GluN2C expression rescues early epilepsy in a tuberous sclerosis murine model
- (2014) N. Lozovaya et al. Nature Communications
- mTOR signaling and its roles in normal and abnormal brain development
- (2014) Nobuyuki Takei et al. Frontiers in Molecular Neuroscience
- Evolving neurobiology of tuberous sclerosis complex
- (2013) Peter B. Crino ACTA NEUROPATHOLOGICA
- TORC1-dependent epilepsy caused by acute biallelicTsc1deletion in adult mice
- (2013) Elisabeth Abs et al. ANNALS OF NEUROLOGY
- Epilepsy in TSC: Certain etiology does not mean certain prognosis
- (2013) Aglaia Vignoli et al. EPILEPSIA
- Pacemaker GABA synaptic activity may contribute to network synchronization in pediatric cortical dysplasia
- (2013) Carlos Cepeda et al. NEUROBIOLOGY OF DISEASE
- Cytoarchitectural alterations are widespread in cerebral cortex in tuberous sclerosis complex
- (2012) Leah Marcotte et al. ACTA NEUROPATHOLOGICA
- Fetal Brain Lesions in Tuberous Sclerosis Complex: TORC1 Activation and Inflammation
- (2012) Avanita S. Prabowo et al. BRAIN PATHOLOGY
- mTOR Signaling in Growth Control and Disease
- (2012) Mathieu Laplante et al. CELL
- Fetal Brain mTOR Signaling Activation in Tuberous Sclerosis Complex
- (2012) Victoria Tsai et al. CEREBRAL CORTEX
- Mammalian Target of Rapamycin (mTOR) Inhibition: Potential for Antiseizure, Antiepileptogenic, and Epileptostatic Therapy
- (2012) Robin C. C. Ryther et al. Current Neurology and Neuroscience Reports
- Identification of new epilepsy treatments: Issues in preclinical methodology
- (2012) Aristea S. Galanopoulou et al. EPILEPSIA
- Finding a better drug for epilepsy: The mTOR pathway as an antiepileptogenic target
- (2012) Aristea S. Galanopoulou et al. EPILEPSIA
- Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial
- (2012) David Neal Franz et al. LANCET
- Autistic-like behaviour and cerebellar dysfunction in Purkinje cell Tsc1 mutant mice
- (2012) Peter T. Tsai et al. NATURE
- The Interaction between Early Life Epilepsy and Autistic-Like Behavioral Consequences: A Role for the Mammalian Target of Rapamycin (mTOR) Pathway
- (2012) Delia M. Talos et al. PLoS One
- The mTOR Inhibitor Rapamycin Has Limited Acute Anticonvulsant Effects in Mice
- (2012) Adam L. Hartman et al. PLoS One
- Rapamycin-Induced Insulin Resistance Is Mediated by mTORC2 Loss and Uncoupled from Longevity
- (2012) D. W. Lamming et al. SCIENCE
- Rapamycin reverses impaired social interaction in mouse models of tuberous sclerosis complex
- (2012) Atsushi Sato et al. Nature Communications
- Loss of White Matter Microstructural Integrity Is Associated with Adverse Neurological Outcome in Tuberous Sclerosis Complex
- (2011) Jurriaan M. Peters et al. ACADEMIC RADIOLOGY
- GABAergic Interneuron Development and Function Is Modulated by the Tsc1 Gene
- (2011) Cary Fu et al. CEREBRAL CORTEX
- The ketogenic diet inhibits the mammalian target of rapamycin (mTOR) pathway
- (2011) Sharon S. McDaniel et al. EPILEPSIA
- Long-term neurological outcome in children with early-onset epilepsy associated with tuberous sclerosis
- (2011) Raffaella Cusmai et al. EPILEPSY & BEHAVIOR
- Low glycemic index treatment for epilepsy in tuberous sclerosis complex
- (2011) Anna M. Larson et al. EPILEPSY RESEARCH
- Therapeutic value of prenatal rapamycin treatment in a mouse brain model of tuberous sclerosis complex
- (2011) S. Anderl et al. HUMAN MOLECULAR GENETICS
- Enhanced GABAergic network and receptor function in pediatric cortical dysplasia Type IIB compared with Tuberous Sclerosis Complex
- (2011) Carlos Cepeda et al. NEUROBIOLOGY OF DISEASE
- Neuronal and glia abnormalities in Tsc1-deficient forebrain and partial rescue by rapamycin
- (2011) Robert P. Carson et al. NEUROBIOLOGY OF DISEASE
- Do tubers contain function? Resection of epileptogenic foci in perirolandic cortex in children with tuberous sclerosis complex
- (2010) Yaron A. Moshel et al. EPILEPSIA
- MRI findings reveal three different types of tubers in patients with tuberous sclerosis complex
- (2010) Anne Gallagher et al. JOURNAL OF NEUROLOGY
- Vagus Nerve Stimulation for Refractory Epilepsy in Tuberous Sclerosis
- (2010) Nelia Zamponi et al. PEDIATRIC NEUROLOGY
- Rapamycin suppresses seizures and neuronal hypertrophy in a mouse model of cortical dysplasia
- (2009) M. C. Ljungberg et al. Disease Models & Mechanisms
- Progressive multifocal cystlike cortical tubers in tuberous sclerosis complex: Clinical and neuropathologic findings
- (2009) Catherine J. Chu-Shore et al. EPILEPSIA
- The natural history of epilepsy in tuberous sclerosis complex
- (2009) Catherine J. Chu-Shore et al. EPILEPSIA
- Associations between electroencephalographic and magnetic resonance imaging findings in tuberous sclerosis complex
- (2009) Anne Gallagher et al. EPILEPSY RESEARCH
- Early control of seizures improves long-term outcome in children with tuberous sclerosis complex
- (2009) Roberta Bombardieri et al. EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY
- An ATP-competitive Mammalian Target of Rapamycin Inhibitor Reveals Rapamycin-resistant Functions of mTORC1
- (2009) Carson C. Thoreen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Rapamycin and tuberous sclerosis complex: From Easter Island to epilepsy
- (2008) Peter B. Crino ANNALS OF NEUROLOGY
- Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex
- (2008) Ling-Hui Zeng et al. ANNALS OF NEUROLOGY
- Recent advances in neurobiology of Tuberous Sclerosis Complex
- (2008) Valerio Napolioni et al. BRAIN & DEVELOPMENT
- Are cortical tubers epileptogenic? Evidence from electrocorticography
- (2008) Philippe Major et al. EPILEPSIA
- Response of a Neuronal Model of Tuberous Sclerosis to Mammalian Target of Rapamycin (mTOR) Inhibitors: Effects on mTORC1 and Akt Signaling Lead to Improved Survival and Function
- (2008) L. Meikle et al. JOURNAL OF NEUROSCIENCE
- Tuberous sclerosis
- (2008) Paolo Curatolo et al. LANCET
- Reversal of learning deficits in a Tsc2 +/− mouse model of tuberous sclerosis
- (2008) Dan Ehninger et al. NATURE MEDICINE
- Clinicopathological and immunohistochemical findings in an autopsy case of tuberous sclerosis complex
- (2008) Karin Boer et al. NEUROPATHOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now